BrightSpec
Share
BrightSpec is the first and only company to commercialize the breakthrough capabilities of MRR, Mole
11/10/2020
Do you know your structures? If not, BrightSpec’s MRR can provide the answer!
Win a prize by choosing the correct structure. Which of these molecules is the active form of Ibuprofen?
https://media-exp1.licdn.com/dms/image/C4D22AQEAnvgr7dLbRw/feedshare-shrink_1280-alternative/0?e=1608163200&v=beta&t=OSRd1xHkoqI07XebLY10WpcUeeMeQYGY7r1E-0jF6rY
Enter your answer to win…
https://lnkd.in/dsDqRc4
No alternative text description for this image
09/20/2020
Life on Venus? This discovery work was driven by spectra from mm wave rotational spectroscopy. With many on the team having done academic work in space research, BrightSpec has mm wave instruments in its portfolio, in addition to mw instruments for larger molecules found here on Earth. No matter which part of the universe you are focused on, BrightSpec can help!
Life on Venus? Astronomers See a Signal in Its Clouds The detection of a gas in the planet’s atmosphere could turn scientists’ gaze to a planet long overlooked in the search for extraterrestrial life.
05/20/2020
Congratulations to Dean Harmon et al for this important publication in Nature!
Preparation of cyclohexene isotopologues and stereoisotopomers from benzene Cyclohexene isotopologues and stereoisotopomers with varying degrees of deuteration are formed by binding a tungsten complex to benzene, which facilitates the selective incorporation of deuterium into any position on the ring.
05/19/2020
Congratulations to BrightSpec advisor Frank Gupton and team for receiving funding for this important project! BrightSpec looks forward to working with Phlow to make this happen.
Trump administration taps startup to build stockpile of key drug ingredients The $354 million project is designed to shore up the drug supply chain and reduce the country's dependence on foreign manufacturers.
05/15/2020
White House preparing executive order requiring certain essential drugs be made in US, sources say The White House is preparing an executive order which will require certain essential drugs be made in the U.S.,sources told CNBC on Thursday.
04/29/2020
A lot of important points about the drug supply chain in this article. Tools that enable modern drug manufacturing techniques, lowering cost while increasing safety are critical to strengthening the drug supply. BrightSpec has several years of development enabling just that.
Opinion | Relying on Foreign Drugs Is Dangerous Generics are often made in India, with ingredients from China. Time to diversify the supply chain.
04/13/2020
Covid-19 will spur a renaissance in U.S. drug manufacturing.
This hydroxychloroquine shortage is one of several breakdowns related to overseas manufacture of our API's and drugs. The pharma industry has resisted adopting new technologies such as continuous manufacturing given the more proven regulatory pathway of batch manufacturing and the low cost sourcing options overseas. Leave it to a crisis for the government and industry to recognize the imperatives of domestic manufacture. Continuous manufacturing, enabled by technologies such as BrightSpec MRR which can monitor processes in real-time, will enable domestic drug manufacture at lower cost, faster scale-up of production, and a higher quality and hence safer product. I'm looking forward to help make this a reality.
https://lnkd.in/eYhDxDw hashtag hashtag hashtag hashtag hashtag hashtag
In a rush to contribute an antimalarial med to the COVID-19 fight, drugmakers have promised millions of doses for clinical trials and hospitals. But one company, Amneal Pharmaceuticals, likely won't hit its pledge after the government of Finland effectively turned off the tap for necessary ingredien...
FIERCEPHARMA.COM
Amneal faces hydroxychloroquine API shortage after Finland tightens production: report
In a rush to contribute an antimalarial med to the COVID-19 fight, drugmakers have promised millions of doses for clinical trials and hospitals. But one company, Amneal Pharmaceuticals, likely won't hit its pledge after the government of Finland effectively turned off the tap for necessary ingredien...
Amneal faces hydroxychloroquine API shortage after Finland tightens production: report In a rush to contribute an antimalarial med to the COVID-19 fight, drugmakers have promised millions of doses for clinical trials and hospitals. But one company, Amneal Pharmaceuticals, likely won't hit its pledge after the government of Finland effectively turned off the tap for necessary ingredien...
Thank you for visiting BrightSpec's page. You can learn more about BrightSpec at www.brightspec.com
Click here to claim your Sponsored Listing.
Category
Contact the business
Telephone
Website
Address
Charlottesville, VA